Cargando…
Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579437/ https://www.ncbi.nlm.nih.gov/pubmed/34803484 http://dx.doi.org/10.7150/ijbs.66938 |
Ejemplares similares
-
Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma
por: Zhang, Qian-Qian, et al.
Publicado: (2014) -
Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma: Erratum
por: Zhang, Qian-Qian, et al.
Publicado: (2020) -
Retracted: AXL Inhibits Proinflammatory Factors to Relieve Rheumatoid Arthritis Pain by Regulating the TLR4/NF-κB Signaling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Butylphthalide Inhibits TLR4/NF-κB Pathway by Upregulation of miR-21 to Have the Neuroprotective Effect
por: Healthcare Engineering, Journal of
Publicado: (2023) -
[Retracted] Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway
por: Liu, Jiaguo, et al.
Publicado: (2023)